Rasilez Hct 300 mg/12.5 mg Tablet
Prescription Required
Product introduction
Rasilez Hct 300 mg/12.5 mg Tablet is a combination of two medicines used in the treatment of hypertension (high blood pressure). This medicine relaxes the blood vessels thus helps in lowering the blood pressure.
Rasilez Hct 300 mg/12.5 mg Tablet is a combination of two medicines used in the treatment of hypertension (high blood pressure). This medicine relaxes the blood vessels thus helps in lowering the blood pressure. Moreover, it reduces the extra amount of water in the body by increasing urination. It may also help to reduce chances of future heart attack and stroke. This medicine should be taken with food regularly at a fixed time each day. Lifestyle changes like low-fat diet, exercise, and not smoking may help this medicine work better. This medicine may cause side effects like dizziness, cough, and joint pain.
Rasilez Hct 300 mg/12.5 mg Tablet is a combination of two medicines used in the treatment of hypertension (high blood pressure). This medicine relaxes the blood vessels thus helps in lowering the blood pressure. Moreover, it reduces the extra amount of water in the body by increasing urination. It may also help to reduce chances of future heart attack and stroke. This medicine should be taken with food regularly at a fixed time each day. Lifestyle changes like low-fat diet, exercise, and not smoking may help this medicine work better. This medicine may cause side effects like dizziness, cough, and joint pain.
Uses of Rasilez Hct Tablet
Benefits of Rasilez Hct Tablet
In Hypertension (high blood pressure)
Rasilez Hct 300 mg/12.5 mg Tablet relaxes the blood vessels so that blood can flow more easily around your body. It also eliminates excess water from the body and increases urine output. This lowers your blood pressure and reduces your risk of having a stroke, a heart attack, or kidney problems in the future. You do not usually feel any direct benefit from taking this medicine, but it works in the long term to keep you well. You should take it regularly as prescribed for this medicine to be most effective, even if you feel better.
Side effects of Rasilez Hct Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Rasilez Hct
- Joint pain
- Dizziness
- Tiredness
- Flu-like symptoms
- Vertigo
- Increased potassium level in blood
- Cough
How to use Rasilez Hct Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Rasilez Hct 300 mg/12.5 mg Tablet is to be taken with food.
How Rasilez Hct Tablet works
Rasilez Hct 300 mg/12.5 mg Tablet is a combination of two medicines: Aliskiren and Hydrochlorothiazide. Aliskiren is a direct renin inhibitor. It works by blocking an enzyme (renin) which causes the blood vessels to tighten. This relaxes blood vessels, lowers blood pressure and allows the heart to pump more efficiently. Hydrochlorothiazide is a diuretic. It removes extra water and certain electrolytes from the body by increasing the amount of urine produced. Over time it also works by relaxing blood vessels and improves blood flow.
Safety advice
Alcohol
UNSAFE
Rasilez Hct 300 mg/12.5 mg Tablet may cause excessive drowsiness with alcohol.
Pregnancy
CONSULT YOUR DOCTOR
Rasilez Hct 300 mg/12.5 mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Rasilez Hct 300 mg/12.5 mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
UNSAFE
Rasilez Hct 300 mg/12.5 mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CAUTION
Rasilez Hct 300 mg/12.5 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Rasilez Hct 300 mg/12.5 mg Tablet may be needed. Please consult your doctor.
Limited information is available on the use of Rasilez Hct 300 mg/12.5 mg Tablet in these patients. Regular monitoring of creatinine and potassium levels is recommended while you are taking this medicine.
Limited information is available on the use of Rasilez Hct 300 mg/12.5 mg Tablet in these patients. Regular monitoring of creatinine and potassium levels is recommended while you are taking this medicine.
Liver
CAUTION
Rasilez Hct 300 mg/12.5 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Rasilez Hct 300 mg/12.5 mg Tablet may be needed. Please consult your doctor.
What if you forget to take Rasilez Hct Tablet?
If you miss a dose of Rasilez Hct 300 mg/12.5 mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- For better results, take it at the same time every day with food.
- It may cause dizziness or sleepiness. Don't drive or do anything requiring concentration until you know how it affects you.
- Avoid alcohol while taking Rasilez Hct 300 mg/12.5 mg Tablet as it may increase dizziness.
- Notify your doctor if you have rapid swelling of the lips, tongue, and throat that may cause breathing problems.
- It may cause a sudden drop in sodium level in blood. Avoid a low sodium diet while you are taking this medication.
- Monitor your blood pressure after starting Rasilez Hct 300 mg/12.5 mg Tablet, and notify your doctor if it does not lower down.
Fact Box
Habit Forming
No
Therapeutic Class
CARDIAC
Patient concerns
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Aliskiren and hydrochlorothiazide. Wehr, Germany: Novartis Pharma Produktions GmbH; 2008. [Accessed 11 Apr. 2019] (online) Available from:
- European Medicines Agency. Aliskiren / hydrochlorothiazide. [Accessed 11 Apr. 2019] (online) Available from:
- Aliskiren+Hydrochlorothiazide. Ireland: Noden Pharma DAC; [Accessed 11 Apr. 2019] (online) Available from:
Marketer details
Name: Novartis India Ltd
Address: Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
DISCONTINUED
We do not facilitate sale of this product at present